Document is current
Any future updates will be listed below
-
Authors
Schultze-Florey, Christian R. https://orcid.org/0000-0002-3307-2639
Thol, Felicitas R. https://orcid.org/0000-0001-5848-6152
Aleksandrova, Krasimira
Stoyanov, Kalin
Gutierrez Jauregui, Rodrigo
Arseniev, Lubomir
Leise, Jana
Klöß, Stephan
Heidel, Florian H. https://orcid.org/0000-0003-2438-1955
Tiede, Andreas https://orcid.org/0000-0002-3600-8536
- License Information
-
More Information
Article History
Received: 9 January 2025
Revised: 30 January 2025
Accepted: 24 February 2025
First Online: 8 March 2025
Competing interests
: There are no competing interests related to this study. The study received no commercial funding. CRSF served as an advisor to BMS, Janssen, Kite/Gilead and Pierre Fabre. FRT served as an advisor to Novartis, BMS, AbbVie, Menarini, Rigel and received an honorarium from Astellas and AbbVie. FHH served as an advisor for Novartis, CTI, Celgene/BMS, Janssen, Abbvie, GSK, Merck and AOP and received research funding from Novartis, Celgene/BMS and CTI unrelated to this report. AT reports institutional grants for research and studies from Bayer, Biotest, Chugai, Novo Nordisk, Octapharma, Pfizer, Roche, SOBI, and Takeda, and honoraria for lectures or consultancy from Bayer, Biomarin, Biotest, Chugai, CSL Behring, Novo Nordisk, Octapharma, Pfizer, Roche, SOBI, and Takeda, all unrelated to this report. All other authors declare no conflict of interest related to the content of the manuscript.
